CN Patent

CN117298040A — 一种富马酸伏诺拉生注射液及其制备方法

Assigned to Shandong New Time Pharmaceutical Co Ltd · Expires 2023-12-29 · 2y expired

What this patent protects

本发明提供了一种富马酸伏诺拉生注射液及其制备方法，属于药物制剂技术领域，所述注射液由富马酸伏诺拉生、pH调节剂、氯化钠及注射用水组成；本发明提供的制备方法是先将富马酸伏诺拉生、氯化钠溶于注射用水中，调节合适的pH值后，灌封于棕色安瓿瓶中，充入惰性气体，灭菌。本发明制备的富马酸伏诺拉生注射液杂质少，产品稳定性好，无菌保证水平高。

USPTO Abstract

本发明提供了一种富马酸伏诺拉生注射液及其制备方法，属于药物制剂技术领域，所述注射液由富马酸伏诺拉生、pH调节剂、氯化钠及注射用水组成；本发明提供的制备方法是先将富马酸伏诺拉生、氯化钠溶于注射用水中，调节合适的pH值后，灌封于棕色安瓿瓶中，充入惰性气体，灭菌。本发明制备的富马酸伏诺拉生注射液杂质少，产品稳定性好，无菌保证水平高。

Drugs covered by this patent

Patent Metadata

Patent number
CN117298040A
Jurisdiction
CN
Classification
—
Expires
2023-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Shandong New Time Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.